Mylotarg Archives - Biotech Primer WEEKLY

Amazing Antibodies Part One: Bispecifics & Antibody-Drug Conjugates

by Stacey Hawkins | Aug 2, 2018 | Immunotherapies

Attack Of The Mono- & Polyclonals Monoclonal antibody (mAb) therapeutics burst onto the healthcare scene twenty years ago. They remain one of the most versatile and effective therapies available for a whole range of diseases including different types of cancers,...

Amazing Antibodies Part One: Bispecifics & Antibody-Drug Conjugates

About Biotech Primer

Subscribe to The WEEKLY